PG-101 (ProGen)

N/A

Report date: 2023/03/08 16:27:00

Base Information

Drug NamePG-101 (ProGen)
Drug Alias NamePG-101
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein > Fc fusion protein
Mechanisms of ActionAnti-Glucagon-like peptide-2Interleukin 10 receptor stimulants
TargetsGlucagon-like peptide-2Interleukin 10 receptor
Therapy Area/IndicationsInflammatory Bowel Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesProGen Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesProGen Co Ltd
Inactive CompaniesN/A
Active IndicationsInflammatory Bowel Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A